Insider Transactions in Q1 2022 at Eli Lilly & CO (LLY)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 01
2022
|
Stephen F Fry SVP, HR & Diversity |
BUY
Exercise of conversion of derivative security
|
Direct |
10,170
+6.56%
|
-
|
Feb 01
2022
|
Johna Norton EVP, Global Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
1,194
-4.24%
|
$292,530
$245.39 P/Share
|
Feb 01
2022
|
Johna Norton EVP, Global Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
2,676
+8.68%
|
-
|
Feb 01
2022
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,010
-8.76%
|
$492,450
$245.39 P/Share
|
Feb 01
2022
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
BUY
Exercise of conversion of derivative security
|
Direct |
4,416
+16.14%
|
-
|
Feb 01
2022
|
Anne E. White EVP & Pres, Lilly Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
4,204
-9.73%
|
$1,029,980
$245.39 P/Share
|
Feb 01
2022
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
9,368
+17.82%
|
-
|
Jan 18
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+0.09%
|
$11,362
$247.07 P/Share
|
Jan 18
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
39
+3.45%
|
$9,633
$247.07 P/Share
|
Jan 18
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
51
+0.38%
|
$12,597
$247.07 P/Share
|
Jan 18
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+5.26%
|
$9,880
$247.07 P/Share
|
Jan 18
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+0.06%
|
$9,880
$247.07 P/Share
|